-       Report 
- January 2022
-  120 Pages 
- Global 
   From       €2225EUR$2,500USD£1,958GBP 
          -       Report 
- May 2024
-  160 Pages 
- Global 
   From       €4422EUR$4,969USD£3,892GBP 
          -       Report 
- November 2022
-  565 Pages 
- Global 
   From       €2225EUR$2,500USD£1,958GBP 
          -       Report 
- March 2024
-  117 Pages 
- Global 
   From       €3500EUR$4,213USD£3,189GBP 
          -       Report 
- January 2024
-  110 Pages 
- Global 
   From       €3500EUR$4,213USD£3,189GBP 
                The Stroke Drug market is a subset of the Cardiovascular Drugs market, which includes drugs used to treat and prevent cardiovascular diseases. Stroke drugs are used to treat ischemic and hemorrhagic strokes, which are caused by a disruption of blood flow to the brain. These drugs can help reduce the risk of stroke recurrence and improve patient outcomes. Common stroke drugs include anticoagulants, antiplatelet agents, thrombolytics, and antithrombotics. Anticoagulants are used to prevent blood clots    from forming, while antiplatelet agents are used to prevent existing clots from getting bigger. Thrombolytics are used to dissolve existing clots, while antithrombotics are used to prevent clot formation.
Some companies in the Stroke Drug market include Pfizer, Merck, Sanofi, Bristol-Myers Squibb, and GlaxoSmithKline. Show Less   Read more